Skip to main content
Robert Frantz, MD, Cardiology, Rochester, MN, Mayo Clinic Hospital - Rochester

RobertPFrantzMD

Cardiology Rochester, MN

Adult Congenital Heart Disease, Heart Failure & Transplantation

Cardiology at Mayo Clinic Rochester MN

Dr. Frantz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Frantz's full profile

Already have an account?

Education & Training

  • University of Rochester
    University of RochesterFellowship, Cardiovascular Disease, 1987 - 1990
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1984 - 1987
  • Mayo Clinic College of Medicine
    Mayo Clinic College of MedicineClass of 1984

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1987 - Present
  • IA State Medical License
    IA State Medical License 1993 - 2026
  • WI State Medical License
    WI State Medical License 2014 - 2025
  • ND State Medical License
    ND State Medical License 2009 - 2024
  • MN State Medical License
    MN State Medical License 1985 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Mayo Clinic Interventional Cardiology Board Review 
    Mayo School of Continuous Professional Development, Rochester, Minnesota - 10/12/2012

Authored Content

  • Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
  • Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
  • Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
  • Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
  • Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
  • Join now to see all

Press Mentions

  • Novel PAH Drug Shows Promise in Mid-Stage Trial
    Novel PAH Drug Shows Promise in Mid-Stage TrialMay 23rd, 2023
  • I’m Aware That I’m Rare: Robert P. Frantz, MD
    I’m Aware That I’m Rare: Robert P. Frantz, MDNovember 16th, 2018
  • Pulmonary Balloon Angioplasty
    Pulmonary Balloon AngioplastyOctober 2nd, 2017
  • Join now to see all

Grant Support

  • Sildenafil On Alveolar-Capillary Recruitment, Pulmonary Arterial Pressures And ENational Center For Research Resources2005
  • Pulmonary Limitations In Chronic Heart FAILURE: Influence Of ACE Genotype On ExeNational Center For Research Resources2005

Professional Memberships

Hospital Affiliations